Martin J. Coffey,Reza Haque,Ngumah Quintus,Mohannad Shawer,Jinzhong Zhang
申请号：
US13469853
公开号：
US20120252756A1
申请日:
2012.05.11
申请国别(地区):
US
年份:
2012
代理人:
摘要：
A pharmaceutical composition comprises a polyethylene glycol having a molecular weight in the range from about 1,000 to about 10,000, and a water-soluble cellulose derivative having a molecular weight in the range from about 50,000 to 120,000. The composition can further comprise boric acid and/or phosphate, a non-ionic surfactant, and/or an ophthalmic therapeutic agent. The composition is effective in treating, controlling, ameliorating, or reversing one or more conditions or symptoms of dry eye.
